azauridine has been researched along with Sclerosis, Systemic in 3 studies
Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catalanotto, FA | 1 |
| Slavik, M | 3 |
| Danilson, D | 1 |
| Keiser, HR | 3 |
| Henkin, RI | 2 |
| Lovenberg, W | 1 |
| Danilson, DA | 1 |
3 other studies available for azauridine and Sclerosis, Systemic
| Article | Year |
|---|---|
Changes in preference for NaCl following administration of 6-azauridine and 6-azauridine triacetate.
Topics: Administration, Oral; Adult; Animals; Azauridine; Copper; Differential Threshold; Female; Gastric La | 1975 |
Changes in serum and urine amino acids in patients with progressive systemic sclerosis treated with 6-azauridine triacetate.
Topics: Adult; Alanine; Amino Acids; Aminobutyrates; Azauridine; Female; Homocystine; Humans; Middle Aged; S | 1973 |
Alterations in metabolism of copper and zinc after administration of 6-azauridine triacetate.
Topics: Acetates; Adult; Azauridine; Copper; Female; Humans; Kidney; Middle Aged; Scleroderma, Systemic; Spe | 1973 |